A specific anti‐COVID‐19 BNT162b2 vaccine‐induced early innate immune signature positively correlates with the humoral protective response in healthy and multiple sclerosis vaccine recipients

A specific anti‐COVID‐19 BNT162b2 vaccine‐induced early innate immune signature positively correlates with the humoral protective response in healthy and multiple sclerosis vaccine recipients

Abstract Objectives The very rapidly approved mRNA‐based vaccines against SARS‐CoV‐2 spike glycoprotein, including Pfizer‐BioNTech BNT162b2, are effective in protecting from severe coronavirus disease 2019 (COVID‐19) in immunocompetent population. However, establishing the duration and identifying c...

Full description

Bibliographic Details
Main Authors: Martina Severa, Fabiana Rizzo, Alessandro Sinigaglia, Daniela Ricci, Marilena Paola Etna, Gaia Cola, Doriana Landi, Maria Chiara Buscarinu, Catia Valdarchi, Giovanni Ristori, Silvia Riccetti, Chiara Piubelli, Pierangela Palmerini, Antonio Rosato, Federico Gobbi, Stefano Balducci, Girolama Alessandra Marfia, Marco Salvetti, Luisa Barzon, Eliana Marina Coccia
Format: Article
Language:English
Published: Wiley 2023-01-01
Series:Clinical & Translational Immunology
Subjects:
humoral response
innate immunity
mRNA vaccine
SARS‐CoV‐2
Online Access:https://doi.org/10.1002/cti2.1434

Internet

https://doi.org/10.1002/cti2.1434

Similar Items